000			01378 a2200373 4500
005			20250513054743.0
264		0	_c19940802
008			199408s 0 0 eng d
022			_a0114-5916
024	7		_a10.2165/00002018-199410040-00002 _2doi
040			_aNLM _beng _cNLM
100	1		_aMorris, D J
245	0	0	_aAdverse effects and drug interactions of clinical importance with antiviral drugs. _h[electronic resource]
260			_bDrug safety _cApr 1994
300			_a281-91 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAIDS-Related Opportunistic Infections _xdrug therapy
650	0	4	_aAcyclovir _xadverse effects
650	0	4	_aAmantadine _xadverse effects
650	0	4	_aAntiviral Agents _xadverse effects
650	0	4	_aDidanosine _xadverse effects
650	0	4	_aDrug Interactions
650	0	4	_aFoscarnet _xadverse effects
650	0	4	_aGanciclovir _xadverse effects
650	0	4	_aHumans
650	0	4	_aInterferon-alpha _xadverse effects
650	0	4	_aRibavirin _xadverse effects
650	0	4	_aRimantadine _xadverse effects
650	0	4	_aVidarabine _xadverse effects
650	0	4	_aZalcitabine _xadverse effects
650	0	4	_aZidovudine _xadverse effects
773	0		_tDrug safety _gvol. 10 _gno. 4 _gp. 281-91
856	4	0	_uhttps://doi.org/10.2165/00002018-199410040-00002 _zAvailable from publisher's website
999			_c8017628 _d8017628